{"id":14071,"date":"2020-08-18T12:40:44","date_gmt":"2020-08-18T10:40:44","guid":{"rendered":"https:\/\/idibell.cat\/?p=14071"},"modified":"2020-09-01T10:43:38","modified_gmt":"2020-09-01T08:43:38","slug":"edat-i-sexe-masculi-factors-clau-en-el-risc-de-mortalitat-dingres-hospitalari-per-la-covid-19","status":"publish","type":"post","link":"https:\/\/idibell.cat\/2020\/08\/edat-i-sexe-masculi-factors-clau-en-el-risc-de-mortalitat-dingres-hospitalari-per-la-covid-19\/","title":{"rendered":"Edat i sexe mascul\u00ed, factors clau en el risc de mortalitat d’ingr\u00e9s hospitalari per la COVID-19"},"content":{"rendered":"
Un estudi dut a terme en 127 centres hospitalaris espanyols i amb la participaci\u00f3 de l\u2019IDIBELL suma una informaci\u00f3 completa sobre les complicacions i pron\u00f2stic dels primers 4.035 pacients amb COVID-19 ingressats al pa\u00eds.<\/strong><\/h6>\n

 <\/p>\n

<\/h6>\n
La investigaci\u00f3 tamb\u00e9 ha perm\u00e8s identificar algunes variables que s’associen amb pitjor pron\u00f2stic, el que ser\u00e0 de gran utilitat per a la identificaci\u00f3 d’aquells pacients amb major risc de mort durant l’ingr\u00e9s.<\/strong><\/h6>\n

 <\/p>\n

M\u00e9s de 500 professionals sanitaris de 127 centres hospitalaris, incl\u00f2s el Dr Jordi Carratal\u00e0, metge i investigador a l’Institut d\u2019Investigaci\u00f3 Biom\u00e8dica de Bellvitge (IDIBELL) i l’Hospital Universitari de Bellvitge, han col\u00b7laborat en l’estudi COVID-19@Spain, promogut per la Societat Espanyola de Malalties Infeccioses i Microbiologia Cl\u00ednica (SEIMC) per determinar les caracter\u00edstiques epidemiol\u00f2giques i cl\u00edniques dels pacients hospitalitzats amb COVID-19 en tot el territori espanyol, i identificar els factors predictors de mort.<\/p>\n

La foto fixa i troballes d’aquesta cohort nacional, que va analitzar els primers 4.035 pacients amb COVID-19 ingressats des de l’inici de l’epid\u00e8mia fins el 17 de mar\u00e7 de 2020, mostra que l’edat mitjana va ser de 70 anys, el 25% tenia m\u00e9s de 80 anys, i el 61% eren homes. M\u00e9s del 70% tenia alguna malaltia subjacent i m\u00e9s del 25% patia com a m\u00ednim tres malalties de base. Les m\u00e9s freq\u00fcents van ser hipertensi\u00f3 arterial, cardiopatia cr\u00f2nica, diabetis, MPOC i obesitat.<\/p>\n

Els s\u00edmptomes m\u00e9s comuns van ser febre, tos, malestar general i dificultat per respirar. Durant l’hospitalitzaci\u00f3, un de cada tres pacients va desenvolupar s\u00edndrome del destret respiratori agut, el 18,5% van ingressar a la UCI i el 15,5% van ser sotmesos a ventilaci\u00f3 mec\u00e0nica. Van morir el 28% dels pacients i la mort va oc\u00f3rrer com a mitjana 10 dies despr\u00e9s de l’ingr\u00e9s. La mortalitat va ser de el 59,3% en els pacients amb destret respiratori, de l’54.9% en aquells amb edat igual o superior a 80 anys, de el 47,7% en aquells que tenien tres o m\u00e9s malalties subjacents, de l’45,7% aquells sotmesos a ventilaci\u00f3 mec\u00e0nica i de l’42,4% aquells ingressats a UCI.<\/p>\n

L’an\u00e0lisi estad\u00edstica va posar de manifest l’exist\u00e8ncia de 17 variables que es van associar amb major risc de mort, el m\u00e9s determinant dels quals va ser l’edat. Tamb\u00e9 es van associar amb major risc de mort el sexe mascul\u00ed, la pres\u00e8ncia d’algunes malalties subjacents (hipertensi\u00f3 arterial, obesitat, cirrosi hep\u00e0tica, malaltia neurol\u00f2gica cr\u00f2nica, c\u00e0ncer actiu i dem\u00e8ncia), algunes caracter\u00edstiques cl\u00edniques com dificultat respirat\u00f2ria o disminuci\u00f3 de la consci\u00e8ncia, la baixa oxigenaci\u00f3 de la sang i algunes proves de laboratori com el quocient neutr\u00f2fils\/limf\u00f2cits i la funci\u00f3 renal.<\/p>\n

Val la pena ressaltar que no hi va haver difer\u00e8ncies en la mortalitat ajustada per gravetat entre les diferents zones geogr\u00e0fiques, el que parla a favor de l’homogene\u00eftat en la qualitat assistencial al pa\u00eds.<\/p>\n

Fins a la data, s’han publicat tres cohorts nacionals de pacients hospitalitzats amb COVID-19, dues de la Xina i una de Regne Unit. En totes elles es va fer una descripci\u00f3 m\u00e9s o menys detallada dels pacients, la malaltia i l’evoluci\u00f3; per\u00f2, en cap de les tres es va examinar el paper de les proves de laboratori en el pron\u00f2stic de la malaltia.<\/p>\n

 <\/p>\n

Comit\u00e8 Cient\u00edfic<\/strong><\/p>\n

COVID-19@Spain compta amb un Comit\u00e8 Cient\u00edfic integrat per investigadors cl\u00ednics de diversos hospitals espanyols com l’Hospital Gregorio Mara\u00f1\u00f3n, l’Hospital La Paz i l’Hospital Infanta Leonor de Madrid; els Hospitals Verge Macarena i Verge del Roc\u00edo de Sevilla i l’IDIBELL\/Hospital de Bellvitge a Barcelona. El comit\u00e8 compta a m\u00e9s amb investigadors de el Centre Nacional d’Epidemiologia de l’Institut de Salut Carlos III i de la Fundaci\u00f3 SEIMC-GESIDA.<\/p>\n","protected":false},"excerpt":{"rendered":"

Un estudi amb la participaci\u00f3 de l\u2019IDIBELL suma una informaci\u00f3 completa sobre les complicacions i pron\u00f2stic dels primers 4.035 pacients amb COVID-19 ingressats al pa\u00eds.<\/p>\n","protected":false},"author":8,"featured_media":14072,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"default","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"default","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[391],"tags":[],"class_list":["post-14071","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-infeccions-respiratories-i-en-lhoste-immunocompromes"],"publishpress_future_action":{"enabled":false,"date":"2024-12-01 13:07:27","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category"},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts\/14071","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/comments?post=14071"}],"version-history":[{"count":0,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts\/14071\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/media\/14072"}],"wp:attachment":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/media?parent=14071"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/categories?post=14071"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/tags?post=14071"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}